SlideShare a Scribd company logo
GE Medical Systems
  The Future of Medical Imaging




                                  Group 1
Agenda

• Industry & Company Overview
• Problem Analysis
• Decision Criteria
• Alternatives
• Recommendations
• GE’s actual response
Medical Imaging Industry
                                   New Entrants
                                   • Pharmaceutical
                                      companies?
                                   Biomedical firms?

 Suppliers     Competitors         Intermediaries     Consumers
•    Price-    • Siemens,Philips   •   Direct Sales   • Hospitals
 determined,   • Oligopoly             removes        • Out-patient
  long term                         intermediaries       clinics
   partners
•     Each
produces one                        Substitutes
     part                              • Secondary
                                         market
Medical Industry Trends

     1. Developed vs. Developing Market
     2. Bio-Medicine Vs. Machinery
     3. Demographic changes in developed
        countries


Background
 Overview     Background
             Problem Analysis    Background
                                DC & Alternatives   Background
                                                    Recommendations   Background
                                                                        Conclusion
Company Overview

     • First major product was the x-ray
     • Global Product Company program
     • One of the largest firms in the world by
       market capitalization


Background
 Overview     Background
             Problem Analysis    Background
                                DC & Alternatives   Background
                                                    Recommendations   Background
                                                                        Conclusion
Strengths     Weaknesses




Opportunities     Threats
Strengths                      Weaknesses
•    Strong Global Ties: GPC     •       Unilateral focus on
            Program                     machinery & “best
•       Six Sigma Quality                  engineering”
•   Strong Acquisition History   •   Internally focused strategy



       Opportunities                        Threats
•    Bio-Medicine: “Global       • Bio-Medicine vs. machinery
         Opportunity”              profit & product cycle
•    Aging Baby Boomers          • Reforms in France, U.S.,
•    Emerging middle class        and China have reduced
•        Health Care IT           amount spent on hospital
•    Country-specific trends               capital
Problem Statement
  GEMS is a world-leading medical equipment
  subsidiary of GE that has experienced many
  years of success. However, due to changing
   market conditions, GEMS must change its
    global positioning strategy if it wishes to
              remain competitive.


Background
 Overview       Background
              Problem Analysis    Background
                                 DC & Alternatives   Background
                                                     Recommendations   Background
                                                                         Conclusion
Strategy Assessment within the
            Growth Curve

                    GEMS current
Level of              position
Growth




                         Age of Company
 Background
  Overview      Background
              Problem Analysis    Background
                                 DC & Alternatives   Background
                                                     Recommendations   Background
                                                                         Conclusion
Alternatives

  Target                          Target
Developed                       Developing                  Focus on
 nations &                       nations &               machinery, but
  Change                         Maintain                create R&D for
Technology                      Technology                  Bio-tech



Background
 Overview     Background
             Problem Analysis     Background
                                 DC & Alternatives   Background
                                                     Recommendations   Background
                                                                         Conclusion
Decision Criteria
     1. Increase market share by 15% over the next
        15 years
     2. Develop relationships with business
        partners around the world to better connect
        GEMS with each country it operates in
     3. Ensure short-term profitability is
        maintained
     4. Minimize overall financial risk taken by
        GEMS
Background
 Overview      Background
              Problem Analysis     Background
                                 DC & Alternatives   Background
                                                     Recommendations   Background
                                                                         Conclusion
Evaluating Alternatives
    Alternatives      Decision Criteria

                      Market share    relationship    profitability     risk

    Developed &       3               3               2                1
    maintained
    technology
    Developing        4               3               4                4
    nations &
    change
    technology
    Focus on        5                 4               4                3
    Developing
    nations, but
    develop LT bio-
    tech


Background
 Overview           Background
                   Problem Analysis     Background
                                      DC & Alternatives     Background
                                                            Recommendations   Background
                                                                                Conclusion
Evaluating Alternatives
    Alternatives      Decision Criteria

                      Market share    relationship    profitability     risk

    Developed &       3               3               2                1
    maintained
    technology
    Developing        4               3               4                4
    nations &
    change
    technology
    Focus on        5                 4               4                3
    Developing
    nations, but
    develop LT bio-
    tech


Background
 Overview           Background
                   Problem Analysis   DC & Alternatives     Background
                                                            Recommendations   Background
                                                                                Conclusion
Recommendations
        Short-Term Focus                        Long-Term Focus
   •      Improve                                     •    Create new
    secondary market             •  Manage                department
          supply                 relationships        • Monitor trend
   • Standardize                     with             •     Work with
   restoration process            developing               regulators
   •      Minimize                  nations           • Educate market on
      manufacturing                                      personalized
       inefficiencies                                        medicine



Background
 Overview      Background
              Problem Analysis     Background
                                  DC & Alternatives    Background
                                                       Recommendations   Conclusion
What is GEMS doing now?

      • Name changed to GE Healthcare
      • Horizontal Integration: Acquisitions
        remain important
      • Lesser focus on secondary market
      • Financial Crisis: drive down cost

 Background
  Overview     Background
              Problem Analysis    Background
                                 DC & Alternatives   Background
                                                     Recommendations   Background
                                                                        Conclusion
Questions
• What alternative would you have
  chosen? Why? Do you see another
  alternative GEMS should consider?
• What do you think is the most
  important trend in the health care
  sector?
• Is this industry better suited to a global
  strategy or a localized strategy?

More Related Content

What's hot

Sainsbury in Egypt
Sainsbury in EgyptSainsbury in Egypt
Sainsbury in Egypt
shikhar bhatnagar
 
Strategic Review and Analysis of Egon Zehnder
Strategic Review and Analysis of Egon ZehnderStrategic Review and Analysis of Egon Zehnder
Strategic Review and Analysis of Egon Zehnder
Mathan Anto Marshine
 
emerging nokia - should they focus on developed or emerging markets
 emerging nokia - should they focus on developed or emerging markets emerging nokia - should they focus on developed or emerging markets
emerging nokia - should they focus on developed or emerging markets
Saurabh Arora
 
Pepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review CasePepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review Case
Famy
 
Cola Wars Continue: Coke and Pepsi in 2010
Cola Wars Continue: Coke and Pepsi in 2010Cola Wars Continue: Coke and Pepsi in 2010
Cola Wars Continue: Coke and Pepsi in 2010
Sharon
 
TruEarth Healthy Food
TruEarth Healthy FoodTruEarth Healthy Food
TruEarth Healthy Food
ShivamKumarPandey5
 
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
 cola-wars-continue-coke-and-pepsi-in-2006-by-group-c cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
Rohail Siddique
 
The Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
The Walt Disney Company and Pixar Inc.: To Acquire or Not to AcquireThe Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
The Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
Eric Moon
 
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
Arjun Parekh
 
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
Akshay Jain
 
BMW in Greece
 BMW in Greece BMW in Greece
BMW in Greece
Gareth Jones
 
Harrington case
Harrington case Harrington case
Harrington case
Nandita Choudhury
 
Tate’s Digital Strategy: The Times They Are A-Changin’
Tate’s Digital Strategy: The Times They Are A-Changin’ Tate’s Digital Strategy: The Times They Are A-Changin’
Tate’s Digital Strategy: The Times They Are A-Changin’
Museums Computer Group
 
Designs by kate
Designs by kateDesigns by kate
Designs by kate
Neens
 
The Harvard Graduate Student Housing Survey
The Harvard Graduate Student Housing SurveyThe Harvard Graduate Student Housing Survey
The Harvard Graduate Student Housing Survey
Arushi Verma
 
Apex corporation case study
Apex corporation case studyApex corporation case study
Apex corporation case study
Utkarsh Shivam
 
Dell Computers (A) : Field Service for Corporate Clients
Dell Computers (A) : Field Service for Corporate Clients Dell Computers (A) : Field Service for Corporate Clients
Dell Computers (A) : Field Service for Corporate Clients
Vijay Somu
 
Jsw shoppe
Jsw shoppeJsw shoppe
Jsw shoppe
Jay K Garg
 
Culinarian cookware
Culinarian cookwareCulinarian cookware
Culinarian cookware
Sindoor Naik
 

What's hot (20)

Sainsbury in Egypt
Sainsbury in EgyptSainsbury in Egypt
Sainsbury in Egypt
 
Strategic Review and Analysis of Egon Zehnder
Strategic Review and Analysis of Egon ZehnderStrategic Review and Analysis of Egon Zehnder
Strategic Review and Analysis of Egon Zehnder
 
emerging nokia - should they focus on developed or emerging markets
 emerging nokia - should they focus on developed or emerging markets emerging nokia - should they focus on developed or emerging markets
emerging nokia - should they focus on developed or emerging markets
 
Pepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review CasePepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review Case
 
Cola Wars Continue: Coke and Pepsi in 2010
Cola Wars Continue: Coke and Pepsi in 2010Cola Wars Continue: Coke and Pepsi in 2010
Cola Wars Continue: Coke and Pepsi in 2010
 
TruEarth Healthy Food
TruEarth Healthy FoodTruEarth Healthy Food
TruEarth Healthy Food
 
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
 cola-wars-continue-coke-and-pepsi-in-2006-by-group-c cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
 
Cyworld
CyworldCyworld
Cyworld
 
The Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
The Walt Disney Company and Pixar Inc.: To Acquire or Not to AcquireThe Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
The Walt Disney Company and Pixar Inc.: To Acquire or Not to Acquire
 
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
Aqualisa Quartz - Simply A Better Shower (HBR Case Study)
 
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
ATLANTIC COMPUTER: A BUNDLE OF PRICING OPTIONS
 
BMW in Greece
 BMW in Greece BMW in Greece
BMW in Greece
 
Harrington case
Harrington case Harrington case
Harrington case
 
Tate’s Digital Strategy: The Times They Are A-Changin’
Tate’s Digital Strategy: The Times They Are A-Changin’ Tate’s Digital Strategy: The Times They Are A-Changin’
Tate’s Digital Strategy: The Times They Are A-Changin’
 
Designs by kate
Designs by kateDesigns by kate
Designs by kate
 
The Harvard Graduate Student Housing Survey
The Harvard Graduate Student Housing SurveyThe Harvard Graduate Student Housing Survey
The Harvard Graduate Student Housing Survey
 
Apex corporation case study
Apex corporation case studyApex corporation case study
Apex corporation case study
 
Dell Computers (A) : Field Service for Corporate Clients
Dell Computers (A) : Field Service for Corporate Clients Dell Computers (A) : Field Service for Corporate Clients
Dell Computers (A) : Field Service for Corporate Clients
 
Jsw shoppe
Jsw shoppeJsw shoppe
Jsw shoppe
 
Culinarian cookware
Culinarian cookwareCulinarian cookware
Culinarian cookware
 

Similar to GE Medical Systems Case Study

BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010chalverson
 
Ranbaxy singapore
Ranbaxy singapore Ranbaxy singapore
Ranbaxy singapore Baba Thakur
 
Healthymagination at GE
Healthymagination at GEHealthymagination at GE
Healthymagination at GE
Josh Keck
 
Linking competitive intelligence to decisions
Linking competitive intelligence to decisionsLinking competitive intelligence to decisions
Linking competitive intelligence to decisionsDavid Harkleroad
 
Med Week Final - Arete Leadership Consulting
Med Week Final - Arete Leadership ConsultingMed Week Final - Arete Leadership Consulting
Med Week Final - Arete Leadership ConsultingALC
 
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...Datamonitor Consulting
 
Three Ways to Minimize Market Risk
Three Ways to Minimize Market RiskThree Ways to Minimize Market Risk
Three Ways to Minimize Market Risk
Endeavor Management
 
Q2 2012 Update
Q2 2012 UpdateQ2 2012 Update
Q2 2012 Update
andrewlevitch
 
Ge Multinational Corporations Presentation
Ge Multinational Corporations PresentationGe Multinational Corporations Presentation
Ge Multinational Corporations PresentationIsis Quiñones
 
Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies
Best Practices and Points to Consider for Small-Medium Bio-Pharma CompaniesBest Practices and Points to Consider for Small-Medium Bio-Pharma Companies
Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies
Covance
 
Cddi Corporate Presentation
Cddi Corporate PresentationCddi Corporate Presentation
Cddi Corporate Presentationitsbernardchan
 
Quality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONQuality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONkkukor
 
Case Study "Research in Motion"
Case Study "Research in Motion"Case Study "Research in Motion"
Case Study "Research in Motion"
David Green
 
Best Practices in Forecasting & Optimization
Best Practices in Forecasting & OptimizationBest Practices in Forecasting & Optimization
Best Practices in Forecasting & Optimization
M/A/R/C Research
 
The path to implementing global payroll for international (MultiNational) com...
The path to implementing global payroll for international (MultiNational) com...The path to implementing global payroll for international (MultiNational) com...
The path to implementing global payroll for international (MultiNational) com...
Chris Bradshaw
 
Bus475.Nov09.3
Bus475.Nov09.3Bus475.Nov09.3
Bus475.Nov09.3
Lawrence
 
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...thenuscase
 
Marketsensus presentation april 2011
Marketsensus presentation april 2011Marketsensus presentation april 2011
Marketsensus presentation april 2011
Marketsensus Research and Innovation
 
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
Gebhard Borck
 

Similar to GE Medical Systems Case Study (20)

BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010
 
Ranbaxy singapore
Ranbaxy singapore Ranbaxy singapore
Ranbaxy singapore
 
Healthymagination at GE
Healthymagination at GEHealthymagination at GE
Healthymagination at GE
 
Linking competitive intelligence to decisions
Linking competitive intelligence to decisionsLinking competitive intelligence to decisions
Linking competitive intelligence to decisions
 
Med Week Final - Arete Leadership Consulting
Med Week Final - Arete Leadership ConsultingMed Week Final - Arete Leadership Consulting
Med Week Final - Arete Leadership Consulting
 
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...
Datamonitor Consulting: Opportunity Assessment and Forecasting in the Pharmac...
 
Three Ways to Minimize Market Risk
Three Ways to Minimize Market RiskThree Ways to Minimize Market Risk
Three Ways to Minimize Market Risk
 
Q2 2012 Update
Q2 2012 UpdateQ2 2012 Update
Q2 2012 Update
 
Ge Multinational Corporations Presentation
Ge Multinational Corporations PresentationGe Multinational Corporations Presentation
Ge Multinational Corporations Presentation
 
Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies
Best Practices and Points to Consider for Small-Medium Bio-Pharma CompaniesBest Practices and Points to Consider for Small-Medium Bio-Pharma Companies
Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies
 
Cddi Corporate Presentation
Cddi Corporate PresentationCddi Corporate Presentation
Cddi Corporate Presentation
 
Market entry an interesting decision
Market entry   an interesting decisionMarket entry   an interesting decision
Market entry an interesting decision
 
Quality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTIONQuality 3.0 THE NEXT REVOLUTION
Quality 3.0 THE NEXT REVOLUTION
 
Case Study "Research in Motion"
Case Study "Research in Motion"Case Study "Research in Motion"
Case Study "Research in Motion"
 
Best Practices in Forecasting & Optimization
Best Practices in Forecasting & OptimizationBest Practices in Forecasting & Optimization
Best Practices in Forecasting & Optimization
 
The path to implementing global payroll for international (MultiNational) com...
The path to implementing global payroll for international (MultiNational) com...The path to implementing global payroll for international (MultiNational) com...
The path to implementing global payroll for international (MultiNational) com...
 
Bus475.Nov09.3
Bus475.Nov09.3Bus475.Nov09.3
Bus475.Nov09.3
 
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...
NUS-DBS International Case Competition 2010 - Thammasat University (1st Runne...
 
Marketsensus presentation april 2011
Marketsensus presentation april 2011Marketsensus presentation april 2011
Marketsensus presentation april 2011
 
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
Seminar (EN): CFO Forum - Challenges in tough times, Warszaw/Poland, organize...
 

GE Medical Systems Case Study

  • 1. GE Medical Systems The Future of Medical Imaging Group 1
  • 2. Agenda • Industry & Company Overview • Problem Analysis • Decision Criteria • Alternatives • Recommendations • GE’s actual response
  • 3. Medical Imaging Industry New Entrants • Pharmaceutical companies? Biomedical firms? Suppliers Competitors Intermediaries Consumers • Price- • Siemens,Philips • Direct Sales • Hospitals determined, • Oligopoly removes • Out-patient long term intermediaries clinics partners • Each produces one Substitutes part • Secondary market
  • 4. Medical Industry Trends 1. Developed vs. Developing Market 2. Bio-Medicine Vs. Machinery 3. Demographic changes in developed countries Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 5. Company Overview • First major product was the x-ray • Global Product Company program • One of the largest firms in the world by market capitalization Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 6. Strengths Weaknesses Opportunities Threats
  • 7. Strengths Weaknesses • Strong Global Ties: GPC • Unilateral focus on Program machinery & “best • Six Sigma Quality engineering” • Strong Acquisition History • Internally focused strategy Opportunities Threats • Bio-Medicine: “Global • Bio-Medicine vs. machinery Opportunity” profit & product cycle • Aging Baby Boomers • Reforms in France, U.S., • Emerging middle class and China have reduced • Health Care IT amount spent on hospital • Country-specific trends capital
  • 8. Problem Statement GEMS is a world-leading medical equipment subsidiary of GE that has experienced many years of success. However, due to changing market conditions, GEMS must change its global positioning strategy if it wishes to remain competitive. Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 9. Strategy Assessment within the Growth Curve GEMS current Level of position Growth Age of Company Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 10. Alternatives Target Target Developed Developing Focus on nations & nations & machinery, but Change Maintain create R&D for Technology Technology Bio-tech Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 11. Decision Criteria 1. Increase market share by 15% over the next 15 years 2. Develop relationships with business partners around the world to better connect GEMS with each country it operates in 3. Ensure short-term profitability is maintained 4. Minimize overall financial risk taken by GEMS Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 12. Evaluating Alternatives Alternatives Decision Criteria Market share relationship profitability risk Developed & 3 3 2 1 maintained technology Developing 4 3 4 4 nations & change technology Focus on 5 4 4 3 Developing nations, but develop LT bio- tech Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 13. Evaluating Alternatives Alternatives Decision Criteria Market share relationship profitability risk Developed & 3 3 2 1 maintained technology Developing 4 3 4 4 nations & change technology Focus on 5 4 4 3 Developing nations, but develop LT bio- tech Background Overview Background Problem Analysis DC & Alternatives Background Recommendations Background Conclusion
  • 14. Recommendations Short-Term Focus Long-Term Focus • Improve • Create new secondary market • Manage department supply relationships • Monitor trend • Standardize with • Work with restoration process developing regulators • Minimize nations • Educate market on manufacturing personalized inefficiencies medicine Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Conclusion
  • 15. What is GEMS doing now? • Name changed to GE Healthcare • Horizontal Integration: Acquisitions remain important • Lesser focus on secondary market • Financial Crisis: drive down cost Background Overview Background Problem Analysis Background DC & Alternatives Background Recommendations Background Conclusion
  • 16. Questions • What alternative would you have chosen? Why? Do you see another alternative GEMS should consider? • What do you think is the most important trend in the health care sector? • Is this industry better suited to a global strategy or a localized strategy?